Cite
HARVARD Citation
Suenaga, M. et al. (n.d.). 471PA phase I study to determine the maximum tolerated dose of trifluridine/tipiracil and oxaliplatin in patients with refractory metastatic colorectal cancer: LUPIN study. Annals of oncology. p. . [Online].